Cyclosporine as cause of thrombotic microangiopathy after renal transplantation [2] (multiple letters)

American Journal of Kidney Diseases

Volumn 29, Issue 5, 1997, Pages 813-814

  Miller, B W ^a   Hmiel, S P ^a   Schnitzler, M A ^a   Brennan, D C ^a   Davis, C L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; VASODILATOR AGENT;

CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LETTER; MAJOR CLINICAL STUDY; NEPHROTOXICITY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0030951897     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90143-8     Document Type: Letter

References (5)

1. BA Young CL Marsh CE Alpers CL Davis Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplant Am J Kidney Dis 28 1996 561 571
2. H Beaufils F degroc MC Gubler B Wochsler P Le Hoang A Baumelou G Chomelte C Jacobs Hemolytic uremic syndrome in patients with Bechet's disease treated with cyclosporine A: Report of 2 cases Clin Nephrol 34 1990 157 162
3. G Feutren MJ Mihatsch Risk factors for cyclosporineinduced neprhopathy in patients with autoimmune diseases N Engl J Med 326 1992 1654 1660
4. M Dhib B Moulin E Abderrahim I Etienne M Godin JP Fillastre Cyclosporine-associated thrombotic microangiopathy: Report of two cases with good outcome and successful subsequent reuse Trans Proc 25 1993 2294 2296
5. LA Hochstetler MJ Flanigan DJ Lager Transplant-associated thrombotic microangiopathy: The role of IgG administration as initial therapy Am J Kidney Dis 23 1994 444 450